Published in Cancer Weekly, July 4th, 2000
"Many mechanisms are involved in tumor-associated antigen (TAA)-specific antibody-based immunotherapy of cancer depending on the nature and specificity of the antibody," said Weimin Qi and colleagues AltaRex Corporation, Massachusetts, reporting at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.